by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Macau-Union Pharmaceutical Limited Warning Letter Details

Warning Letter

Macau-Union Pharmaceutical Limited

3 - 3A Rua Cinco Do Bairro Da Areia Preta Room B 1/F, Industrial Veng Fong Macao SAR China

Issue DateMay 29, 2026

FEI Number3011219786

Violations8

CountryChina

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drugs/Misbranded

Macau-Union Pharmaceutical Limited FDA Warning Letter, May 29, 2026